과제정보
This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (iPET) through the High Value-added Food Technology Development Program, funded by the Ministry of Agriculture, Food AND Rural Affairs (321036051HD040).
참고문헌
- Park SY, Park JH, Kim HS, Lee CY, Lee HJ, Kang KS, et al. 2018. Systems-level mechanisms of action of Panax ginseng: a network pharmacological approach. J. Ginseng Res. 42: 98-106. https://doi.org/10.1016/j.jgr.2017.09.001
- Park YC, Lim JD, Kim JB, Lee S. 2012. Review of red ginseng in terms of mechanisms for pharmacodynamics and toxicity. J. Korean Orient. Med. 33: 200-230. https://doi.org/10.3904/kjm.2012.82.2.200
- Yang XD, Yang YY, Ouyang DS, Yang GP. 2015. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 100: 208-220. https://doi.org/10.1016/j.fitote.2014.11.019
- Ganesan P, Ko HM, Kim IS, Choi DK. 2015. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models. RSC Adv. 5: 98634-98642. https://doi.org/10.1039/C5RA20559J
- Christensen LP, Jensen M. 2009. Biomass and content of ginsenosides and polyacetylenes in American ginseng roots can be increased without affecting the profile of bioactive compounds. J. Nat. Med. 63: 159-168. https://doi.org/10.1007/s11418-008-0307-3
- Park H. 2019. The role of gut microbiota in ginsenoside metabolism and biotransformation of ginsenoside by lactic acid bacteria. Curr. Top. Lact. Acid Bact. Probiotics 5: 1-12. https://doi.org/10.35732/ctlabp.2019.5.1.1
- Shibata S. 2001. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16: Suppl: S28-S37. https://doi.org/10.3346/jkms.2001.16.s.s28
- Han MH, Moon GS. 2019. Bioconversion of ginseng using nicroorganisms. J. Biotechnol. Bioind. 7: 5-11. https://doi.org/10.37503/jbb.2019.7.5
- Akao T, Kanaoka M, Kobashi K. 1998. Appearance of compound a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249. https://doi.org/10.1248/bpb.21.245
- Kim DH. 2009. Metabolism of ginsenosides to bioactive compounds by intestinal microflora and its industrial application. J. Ginseng Res. 33: 165-176. https://doi.org/10.5142/JGR.2009.33.3.165
- Lee J, Lee E, Kim D, Yoo J, Koh B. 2009. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol. 122: 143-148. https://doi.org/10.1016/j.jep.2008.12.012
- Santangelo R, Silvestrini A, Mancuso C. 2019. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions. Food Chem. Toxicol. 123: 42-49. https://doi.org/10.1016/j.fct.2018.10.042
- Bai L, Gao J, Wei F, Zhao J, Wang D, Wei J. 2018. Therapeutic potential of ginsenosides as an adjuvant treatment for diabetes. Front. Pharmacol. 9: 423.
- Yao H, Wan JY, Zeng J, Huang WH, Sava-Segal C, Li L, et al. 2018. Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncol. Lett. 15: 8339-8348.
- Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, et al. 2012. Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer. Int. J. Oncol. 40: 1970-1976.
- Chang KH, Jo MN, Kim HT, Paik HD. 2014. Evaluation of glucosidases of Aspergillus niger strain comparing with other glucosidases in transformation of ginsenoside Rb1 to ginsenosides Rg3. J. Ginseng Res. 38: 47-51. https://doi.org/10.1016/j.jgr.2013.11.008
- Quan K, Liu Q, Wan J, Zhao Y, Guo RZ, Alolga RN, et al. 2015. Rapid preparation of rare ginsenosides by acid transformation and their structure activity relationships against cancer cells. Sci. Rep. 5: 8598.
- Kim MY, Lee JW, Lee KY, Yang DC. 2005. Microbial conversion of major ginsenoside Rb(1) to pharmaceutically active minor ginsenoside Rd. J. Microbiol. 43: 456-462.
- Kim CK. 2012. Ginseng sponins processing by using bio-conversion technology. J. Ginseng Res. 6: 3-13.
- Yoo JM, Lee JY, Lee YG, Baek S, Kim MR. 2018. Enhanced production of compound K in fermented ginseng extracts by Lactobacillus brevis. Food Sci. Biotechnol. 28: 823-829. https://doi.org/10.1007/s10068-018-0504-0
- Park B, Hwang H, Lee J, Sohn SO, Lee SH, Jung MY, et al. 2017. Evaluation of ginsenoside bioconversion of lactic acid bacteria isolated from kimchi. J. Ginseng Res. 41: 524-530. https://doi.org/10.1016/j.jgr.2016.10.003
- Kim JH, Shin MJ, Chung MJ, Kim SH. 2021. Identification of spices promoting the growth of lactic acid bacteria and modulation of tight junction protein at mRNA level by the fermented product of red pepper (Capsicum annuum L.) in HT-29 cell. J. Korean Soc. Food Sci. Nutr. 50: 16-28. https://doi.org/10.3746/jkfn.2021.50.1.16
- Korea Health Supplements Association. 2022. Health Functional Foods Code II, pp. 351-355. KHSA, Seongnam, Gyeonggi, Republic of Korea.
- Ku S, You HJ, Park MS, Ji GE. 2015. Effects of ascorbic acid on α-l-arabinofuranosidase and α-l-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside. J. Korean Soc. Appl. Biol. Chem. 58: 857-865. https://doi.org/10.1007/s13765-015-0113-z
- Bae EA, Park SY, Kim DH. 2000. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23: 1481-1485. https://doi.org/10.1248/bpb.23.1481
- Ku S, You HJ, Park MS, Ji GE. 2016. Whole-cell biocatalysis for producing ginsenoside Rd from Rb1 using Lactobacillus rhamnosus GG. J. Microbiol. Biotechnol. 26: 1206-1215. https://doi.org/10.4014/jmb.1601.01002
- Ku S, You HJ, Park MS, Ji GE. 2015. Effects of ascorbic acid on α-l-arabinofuranosidase and α-l-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside. J. Korean Soc. Appl. Biol. Chem. 58: 857-865. https://doi.org/10.1007/s13765-015-0113-z
- Kim JK, Choi MS, Jeung W, Ra J, Yoo HH, Kim DH. 2020. Effects of gut microbiota on the pharmacokinetics of protopanaxadiol ginsenosides Rd, Rg3, F2, and compound K in healthy volunteers treated orally with red ginseng. J. Ginseng Res. 44: 611-618. https://doi.org/10.1016/j.jgr.2019.05.012
- Kim NM, Lee JS, Lee BH. 2000. Effect of α-amylase on the qualities of red ginseng extract. J. Ginseng. Res. 24: 153-156.